The role of BCG in prevention of leprosy: a meta-analysis (Q33234724)

24 July 2017

0 references

The role of BCG in prevention of leprosy: a meta-analysis (English)

1 reference

24 July 2017

0 references

1 reference

1 reference

Maninder Singh Setia

1

1 reference

24 July 2017

Craig Steinmaus

series ordinal

2

1 reference

24 July 2017

Christine S Ho

series ordinal

3

1 reference

24 July 2017

George W Rutherford

series ordinal

4

1 reference

24 July 2017

1 March 2006

1 reference

Lancet Infectious Diseases

24 July 2017

1 reference

24 July 2017

6

1 reference

24 July 2017

162-170

1 reference

24 July 2017

3

1 reference

Mycobacterium leprae--millennium resistant! Leprosy control on the threshold of a new era.

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

1 reference

7 January 2021

Design of the Leprosy Component of the Brazilian BCG Revaccination Trial for Assessing BCG Effectiveness against Leprosy in School Children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Quantitative methods in the review of epidemiologic literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Epidemiological methods to evaluate vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

BCG vaccination of children against leprosy in Uganda: final results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Vaccination against leprosy at Ben San Leprosy Centre, Ho Chi Minh City, Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Leprosy and BCG in southern Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Protective efficacy of BCG vaccine against leprosy in southern Malaŵi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

B.C.G. vaccination of children against leprosy in Uganda: results at end of second follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Protective efficacy of BCG against leprosy in Northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Leprosy in Malawi. 2. Background, design and prospects of the Karonga Prevention Trial, a leprosy vaccine trial in northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Studies of vaccination of persons in close contact with leprosy patients in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Random-effects meta-analyses are not always conservative.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

How environmental mycobacteria may predetermine the protective efficacy of BCG

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

A historical and molecular phylogeny of BCG strains.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Genetic epidemiology of the susceptibility to leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970412-1

7 January 2021

10.1016/S1473-3099(06)70412-1

Identifiers

DOI

1 reference

24 July 2017

1 reference